Anna M Alvarado
CIK 1729161 · View on SEC EDGAR ↗
First SEC filing: Feb. 1, 2018 · Latest: June 10, 2026
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 9, 2026 | TCBIO | S | 3,500 | $100.95 | $353,325 | 23,810 | — | — | -79.5% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 14, 2025 | TCBIO | 2024 Restricted Stock Units | Common Stock | $0.00 | — | 1,276 | Disposed |
| Feb. 7, 2025 | TCBIO | Restricted Stock Units | Common Stock (1,135) | $0.00 | — | 1,135 | Disposed |
| Feb. 7, 2025 | TCBIO | Restricted Stock Units | Common Stock (1,072) | $0.00 | — | 1,072 | Disposed |
| Feb. 7, 2025 | TCBIO | 2022 Performance Stock Units | Common Stock | $0.00 | March 15, 2025 | 5,542 | Disposed |
| Jan. 28, 2025 | TCBIO | 2025 Restricted Stock Units | Common Stock (3,534) | $0.00 | — | 3,534 | Acquired |
| Nov. 5, 2024 | TCBIO | Restricted Stock Units | Common Stock (5,169) | $0.00 | — | 5,169 | Disposed |
| July 29, 2024 | TCBIO | 2024 Restricted Stock Units | Common Stock (5,700) | $0.00 | — | 5,700 | Acquired |
| Feb. 16, 2024 | TCBIO | 2024 Restricted Stock Units | Common Stock | $0.00 | — | 3,829 | Acquired |
| Feb. 16, 2024 | TCBIO | 2024 Restricted Stock Units | Common Stock (7,658) | $0.00 | — | 7,658 | Acquired |
| Feb. 9, 2024 | TCBIO | Restricted Stock Units | Common Stock (1,134) | $0.00 | — | 1,134 | Disposed |
| Feb. 8, 2024 | TCBIO | Restricted Stock Units | Common Stock (1,071) | $0.00 | — | 1,071 | Disposed |
| Nov. 3, 2023 | TCBIO | Restricted Stock Units | Common Stock (5,170) | $0.00 | — | 5,170 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2021 | $120,909 | $440,000 | $1,300,026 | — | — | — | — | $1,860,935 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.